Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications

References

• Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19.
   PubMedGoogle Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7(2):85–96. doi:10.1038/nrm1837
   PubMed Web of Science ®Google Scholar
• Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106(4):453. doi:10.1172/JCI10762
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi:10.2337/diacare.27.5.1047
   PubMed Web of Science ®Google Scholar
• Christopher B, Newgard CB. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:193–205. doi:10.1038/nrm2327
   PubMedGoogle Scholar
• Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81. doi:10.1097/MED.0b013e3283514e13
   PubMed Web of Science ®Google Scholar
• Ota T. Obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2014;5:204. doi:10.3389/fendo.2014.00204
   PubMed Web of Science ®Google Scholar
• Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60(3):349–356. doi:10.1079/pns2001110
   PubMed Web of Science ®Google Scholar
• Vandanmagsar B, Youm Y-H, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–188. doi:10.1038/nm.2279
   PubMed Web of Science ®Google Scholar
• Nakamura T, Furuhashi M, Li P. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell. 2010;140(3):338–348. doi:10.1016/j.cell.2010.01.001
   PubMed Web of Science ®Google Scholar
• Tanti JF, Ceppo F, Jager J. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 2012;3. doi:10.3389/fendo.2012.00181.
   PubMedGoogle Scholar
• Orr JS, Puglisi MJ, Ellacott KL, et al. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes. 2012;61(11):2718–2727. doi:10.2337/db11-1595
   PubMed Web of Science ®Google Scholar
• Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23(1):87. doi:10.1186/s12929-016-0303-y
   PubMed Web of Science ®Google Scholar
• Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;10:1607. doi:10.3389/fphys.2019.01607
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240–273. doi:10.1128/CMR.00046-08
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Lin H-Y, Shao-Wen W, Shen FC. Abrogation of Toll-like receptor 4 (TLR4) mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria in adipose tissue. Antioxid Redox Signal. 2020;33(2):1–60. doi:10.1089/ars.2019.7737
   PubMedGoogle Scholar
• Gao W, Xiong Y, Li Q, et al. Inhibition of Toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nanotherapeutics. Front Physiol. 2017;8:508–517. doi:10.3389/fphys.2017.00508
   PubMed Web of Science ®Google Scholar
• Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119(5):S10–S6. doi:10.1016/j.amjmed.2006.01.009
   PubMed Web of Science ®Google Scholar
• St-Pierre J, Lin J, Krauss S, et al. Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β. (PGC-1α and PGC-1β) in muscle cells. J Biol Chem. 2003;278(29):26597–26603. doi:10.1074/jbc.M301850200
   PubMed Web of Science ®Google Scholar
• Yuan D, Xiao D, Gao Q, et al. PGC-1α activation: a therapeutic target for type 2 diabetes? Eat Weight Disord. 2019;24(3):385–395. doi:10.1007/s40519-018-0622-y
   PubMedGoogle Scholar
• Roerink SH, Wagenmakers MA, Langenhuijsen JF, et al. Increased adipocyte size, macrophage infiltration, and adverse local adipokine profile in perirenal fat in cushing’s syndrome. Obesity. 2017;25(8). doi:10.1002/oby.21887
   PubMedGoogle Scholar
• Toyoshima Y, Gavrilova O, Yakar S, et al. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology. 2005;146:4024–4035. doi:10.1210/en.2005-0087
   PubMedGoogle Scholar
• Singh P, Sharma P, Sahakyan KR, et al. Differential effects of leptin on adiponectin expression with weight gain versus obesity. Int J Obes. 2016;40:266–274. doi:10.1038/ijo.2015.181
   PubMed Web of Science ®Google Scholar
• Daniele G, Eldor R, Merovci A. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals. Diabetes. 2014;63(8):2812–2820. doi:10.2337/db13-1130
   PubMedGoogle Scholar
• Shimoda Y, Okada S, Yamada E, et al. Tctex1d2 is a negative regulator of GLUT4 translocation and glucose uptake. Endocrinology. 2015;156(10):3548–3558. doi:10.1210/en.2015-1120
   PubMedGoogle Scholar
• You MK, Kim HJ, Rhyu J, et al. Pear pomace ethanol extract improves insulin resistance through enhancement of insulin signaling pathway without lipid accumulation. Nutr Res Pract. 2017;11(3):198–205. doi:10.4162/nrp.2017.11.3.198
   PubMedGoogle Scholar
• Sylow L, Kleinert M, Prats C, et al. AKT and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance. Cell Signal. 2014;26:323–331. doi:10.1016/j.cellsig.2013.11.007
   PubMed Web of Science ®Google Scholar
• Seeley RJ, Woods SC. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci. 2003;4(11):901. doi:10.1038/nrn1245
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339(6116):172–177. doi:10.1126/science.1230721
   PubMed Web of Science ®Google Scholar
• Pocai A, Morgan K, Buettner C, et al. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes. 2005;54(11):3182–3189. doi:10.2337/diabetes.54.11.3182
   PubMedGoogle Scholar
• Fitzgibbons TP, Kogan S, Aouadi M, et al. Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol. 2011;301(4):H1425–37. doi:10.1152/ajpheart.00376.2011
   PubMed Web of Science ®Google Scholar
• Ottaviani E, Malagoli D, Franceschi C. The evolution of the adipose tissue: a neglected enigma. Gen Comp Endocrinol. 2011;174(1):1–4. doi:10.1016/j.ygcen.2011.06.018
   PubMedGoogle Scholar
• Eshima H, Tamura Y, Kakehi S, et al. Long‐term, but not short‐term high‐fat diet induces fiber composition changes and impaired contractile force in mouse fast‐twitch skeletal muscle. Physiol Rep. 2017;5(7):e13250. doi:10.14814/phy2.13250
   PubMedGoogle Scholar
• Badin PM, Louche K, Mairal A, et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes. 2011;60(6):1734–1742. doi:10.2337/db10-1364
   PubMedGoogle Scholar
• Nair KS, Bigelow ML, Asmann YW, et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes. 2008;57(5):1166–1175. doi:10.2337/db07-1556
   PubMedGoogle Scholar
• Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2):121–138. doi:10.1016/j.mam.2012.07.001
   PubMedGoogle Scholar
• Jeschke MG, Boehning D. Endoplasmic reticulum stress and insulin resistance post‐trauma: similarities to type 2 diabetes. J Cell Mol Med. 2012;16(3):437–444. doi:10.1111/j.1582-4934.2011.01405
   PubMedGoogle Scholar
• Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24. doi:10.1007/s11684-013-0262-6
   PubMed Web of Science ®Google Scholar
• Rasouli N. Adipose tissue hypoxia and insulin resistance. J Investig Med. 2016;64(4):830–832. doi:10.1136/jim-2016-000106
   PubMedGoogle Scholar
• Arcidiacono B, Chiefari E, Foryst-Ludwig A, et al. Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance. EBioMedicine. 2020;1:55. doi:10.1016/j.ebiom.2020.102912
   Google Scholar
• Ahima RS. Connecting obesity, aging and diabetes. Nat Med. 2009;15(9):996–997. doi:10.1038/nm0909-996
   PubMed Web of Science ®Google Scholar
• Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging. Diabetes. 2002;51(10):2951–2958. doi:10.2337/diabetes.51.10.2951
   PubMedGoogle Scholar